• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Valeant

Valeant

Page 7 of 12

Senate Banking Committee Hearing with Janet Yellen
Retail

The Fed Meets and China’s Li Talks–5 Things to Know Today

By Geoffrey Smith
March 16, 2016
Berkshire Hathaway Annual Meeting
Finance

Why Bill Ackman Ought to Buy Warren Buffett a Coke

By Jen Wieczner
March 15, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance

Bill Ackman Is Running Out of Options with Valeant

By Stephen Gandel
March 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Valeant’s Shares Are Having An Epically Bad Day

By Jen Wieczner
March 15, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Health

Valeant Just Slashed Its Profit Guidance

By Reuters and Fortune Editors
March 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Here’s What Valeant’s Earnings Tell Us About the Future of the Drug Maker

By Jen Wieczner
March 14, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant Shareholders Push for More Details About CEO’s Illness

By Reuters
March 14, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in  Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
Health

Congress Wants to Know Why Valeant Won’t Hand Over Documents

By Reuters
March 10, 2016
Key Speakers At The 20th Annual Sohn Investment Conference
Finance

Bill Ackman Says a Management Change May Soon Be Necessary at Valeant

By Reuters
March 9, 2016
Hillary Clinton Holds Post-Super Tuesday Rally In NYC
Finance

This Is Why Hillary Clinton’s Attack on Drug Price Hikes Doesn’t Add Up

By Jen Wieczner
March 4, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Valeant’s CEO Called Analysts To Ask For More Time

By Lucinda Shen
March 2, 2016
hillary clinton
Health

Hillary Clinton Says She’s ‘Going After’ Valeant In New Campaign Ad

By Sy Mukherjee
March 1, 2016
Hedge fund manager Bill Ackman
Finance

Bill Ackman Says Valeant Will Be Fine

By Lucinda Shen
March 1, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Leadership

Valeant CEO Michael Pearson to Return from Medical Leave

By Reuters
February 29, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Leadership

Valeant’s CEO Is Feeling Better, But Board May Not Want Him Back

By Jen Wieczner
February 26, 2016

Most Popular

  • AI
    'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
    By Jason Ma
  • Success
    This Stanford computer science professor went to written exams 2 years ago because of AI. He says his students insisted...
    By Nick Lichtenberg
  • Economy
    Top analyst says you weren't crazy for thinking the economy felt worse than it looked the last 3 years. The 'rolling...
    By Nick Lichtenberg
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.